{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:25:49Z","timestamp":1785335149684,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coi.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T19:42:29Z","timestamp":1626118949000},"page":"239-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Inborn errors of IKAROS and AIOLOS"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-1033","authenticated-orcid":false,"given":"Motoi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.06.010_bib0005","first-page":"5229","article-title":"LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes","volume":"11","author":"Lo","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coi.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1439790","article-title":"Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment","volume":"258","author":"Georgopoulos","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.06.010_bib0015","first-page":"7111","article-title":"The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene","volume":"14","author":"Hahm","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coi.2021.06.010_bib0020","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/emboj\/16.8.2004","article-title":"Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation","volume":"16","author":"Morgan","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0960-9822(98)70202-7","article-title":"Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors","volume":"8","author":"Kelley","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.coi.2021.06.010_bib0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1101\/gad.12.6.782","article-title":"Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin","volume":"12","author":"Hahm","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.coi.2021.06.010_bib0035","doi-asserted-by":"crossref","first-page":"38347","DOI":"10.1074\/jbc.M005457200","article-title":"Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities","volume":"275","author":"Perdomo","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2021.06.010_bib0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(03)00043-1","article-title":"Selective dimerization of a C2H2 zinc finger subfamily","volume":"11","author":"McCarty","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.coi.2021.06.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004827","article-title":"The IKAROS interaction with a complex including chromatin remodeling and transcription elongation activities is required for hematopoiesis","volume":"10","author":"Bottardi","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.coi.2021.06.010_bib0050","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1002\/j.1460-2075.1996.tb00920.x","article-title":"Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development","volume":"15","author":"Sun","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2021.06.010_bib0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1101\/gad.297002.117","article-title":"The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma","volume":"31","author":"Georgopoulos","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.coi.2021.06.010_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.11.005","article-title":"The Ikaros family in lymphocyte development","volume":"51","author":"Heizmann","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0065","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9823","article-title":"Ikaros mediates gene silencing in T cells through Polycomb repressive complex 2","volume":"6","author":"Oravecz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2021.06.010_bib0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2009.01.014","article-title":"Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells","volume":"30","author":"Ng","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.immuni.2010.11.008","article-title":"Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis","volume":"33","author":"Arco","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0080","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1101\/gad.283762.116","article-title":"Superenhancer reprogramming drives a B-cell\u2013epithelial transition and high-risk leukemia","volume":"30","author":"Hu","year":"2016","journal-title":"Gene Dev"},{"key":"10.1016\/j.coi.2021.06.010_bib0085","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pbc.23160","article-title":"Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene","volume":"58","author":"Goldman","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.coi.2021.06.010_sbref0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","article-title":"Loss of B cells in patients with heterozygous mutations in IKAROS","volume":"374","author":"Kuehn","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.06.010_sbref0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2016.09.029","article-title":"Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations","volume":"140","author":"Hoshino","year":"2017","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.coi.2021.06.010_bib0100","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1101\/gad.816400","article-title":"Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding","volume":"14","author":"Cobb","year":"2000","journal-title":"Gene Dev"},{"key":"10.1016\/j.coi.2021.06.010_bib0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/leu.2017.25","article-title":"Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia","volume":"31","author":"Yoshida","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.coi.2021.06.010_bib0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2018.04.008","article-title":"A kindred with mutant IKAROS and autoimmunity","volume":"142","author":"Nieuwenhove","year":"2018","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.coi.2021.06.010_bib0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaci.2017.08.019","article-title":"A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B-cell maturation defects","volume":"141","author":"Bogaert","year":"2018","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.coi.2021.06.010_sbref0120","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1172\/JCI98164","article-title":"Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency","volume":"128","author":"Boutboul","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.06.010_bib0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fimmu.2019.00568","article-title":"Assessing the functional relevance of variants in the IKAROS Family Zinc Finger Protein 1 (IKZF1) in a cohort of patients with primary immunodeficiency","volume":"10","author":"Eskandarian","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0130","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/MPH.0000000000001976","article-title":"Common variable immunodeficiency, autoimmune hemolytic anemia, and pancytopenia associated with a defect in IKAROS","volume":"43","author":"Yilmaz","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.coi.2021.06.010_sbref0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.2020007292","article-title":"Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies","volume":"137","author":"Kuehn","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.06.010_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-021-01035-1","article-title":"Abnormal SCID newborn screening and spontaneous recovery associated with a novel haploinsufficiency IKZF1 mutation","author":"Kuehn","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(00)80269-1","article-title":"Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation","volume":"5","author":"Wang","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1074-7613(03)00168-7","article-title":"Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor","volume":"19","author":"Papathanasiou","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0155","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.4049\/jimmunol.1901464","article-title":"A point mutation in IKAROS ZF1 causes a B cell deficiency in mice","volume":"206","author":"Boast","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ni.2828","article-title":"Stage-specific control of early B cell development by the transcription factor Ikaros","volume":"15","author":"Schwickert","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0165","first-page":"160","article-title":"Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells","volume":"15","author":"Schwickert","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.06.010_sbref0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.06.010_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.immuni.2016.06.027","article-title":"Ikaros inhibits group 3 innate lymphoid cell development and function by suppressing the aryl hydrocarbon receptor pathway","volume":"45","author":"Li","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0180","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4049\/jimmunol.1801270","article-title":"Lack of Ikaros deregulates inflammatory gene programs in T cells","volume":"202","author":"de Ana","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18176\/jiaci.0207","article-title":"B-cell deficiency: a de novo IKZF1 patient and review of the literature","volume":"28","author":"Chen","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10875-019-00643-2","article-title":"IKZF1 loss-of-function variant causes autoimmunity and severe familial antiphospholipid syndrome","volume":"39","author":"Dieudonn\u00e9","year":"2019","journal-title":"J Clin immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fped.2019.00139","article-title":"Familial immune thrombocytopenia associated with a novel variant in IKZF1","volume":"7","author":"Sriaroon","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.coi.2021.06.010_bib0200","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S2665-9913(19)30142-0","article-title":"Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts","volume":"2","author":"Belot","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2021.06.010_bib0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.06.010_bib0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR\u2013ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.06.010_bib0215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.06.010_bib0220","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) deletions in BCR-ABL1\u2013positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report","volume":"27","author":"Martinelli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coi.2021.06.010_sbref0225","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","article-title":"Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia","volume":"33","author":"Churchman","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.coi.2021.06.010_bib0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2019.03.025","article-title":"Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant-negative IKFZ1\/IKAROS mutations","volume":"144","author":"Kellner","year":"2019","journal-title":"J Allergy Clin Immun"},{"key":"10.1016\/j.coi.2021.06.010_bib0235","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1074-7613(00)80637-8","article-title":"Aiolos regulates B Cell activation and maturation to effector state","volume":"9","author":"Wang","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1074-7613(01)00135-2","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21","volume":"14","author":"Cariappa","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2021.06.010_bib0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1084\/jem.20031571","article-title":"Aiolos is required for the generation of high affinity bone marrow plasma cells responsible for long-term immunity","volume":"199","author":"Cort\u00e9s","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.06.010_sbref0250","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41590-021-00951-z","article-title":"A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS","volume":"22","author":"Yamashita","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-021-01001-x","article-title":"Selected abstracts from the 12th annual meeting of the clinical immunology society: 2021 virtual annual meeting: immune deficiency and dysregulation North American conference","volume":"41","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_sbref0260","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood.2019000782","article-title":"Germline mutations in the transcription factor IKZF5 cause thrombocytopenia","volume":"134","author":"Lentaigne","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.06.010_bib0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0270","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s10875-021-00980-1","article-title":"The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0275","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3324\/haematol.2016.153023","article-title":"Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients","volume":"102","author":"Scheijen","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2021.06.010_bib0280","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P","article-title":"Ikaros is critical for B cell differentiation and function","volume":"32","author":"Kirstetter","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/MCB.26.1.209-220.2006","article-title":"Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice","volume":"26","author":"Dumortier","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coi.2021.06.010_bib0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","article-title":"The Ikaros gene is required for the development of all lymphoid lineages","volume":"79","author":"Georgopoulos","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.06.010_bib0295","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90170-1","article-title":"A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma","volume":"83","author":"Winandy","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.06.010_bib0300","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.2707","article-title":"Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros","volume":"14","author":"Schjerven","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0305","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10875-020-00798-3","article-title":"Whole-exome sequencing-based approach for germline mutations in patients with inborn errors of immunity","volume":"40","author":"Okano","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.06.010_bib0310","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:49:52Z","timestamp":1760604592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":62,"alternative-id":["S0952791521000790"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.06.010","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn errors of IKAROS and AIOLOS","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}